Prospero B. Gogo, MD

Prospero B. Gogo, MD

Education:

Medical School
George Washington University, Washington, DC

Training:

Residency

University of Vermont/Fletcher Allen Health Care, Burlington, Vermont

Fellowship

University of Vermont/Fletcher Allen Health Care, Burlington, Vermont

Specialty:

Cardiac Catheterization
Percutaneous Coronary Intervention
General Outpatient Cardiology

Certifications:

Internal Medicine
Cardiovascular Disease
Interventional Cardiology

Academic Appointments:

Assistant Professor of Medicine

Biography:

A recent graduate of the Interventional Cardiology Fellowship at the University of Vermont, Dr. Gogo is a specialist in the percutaneous treatment of coronary artery disease and acute coronary syndromes. Additionally, he practices general inpatient and outpatient cardiology at Northwestern Medical Center in St. Albans, VT. Additionally, he is the primary investigator for Gen-X, which will characterize gene expression in the setting of acute coronary syndromes. Dr. Gogo lives in Burlington with his wife, Amy Lilly.

Major Research Interests:

Acute Coronary Syndrome
Vascular Biology
Cardiovascular Imaging

His research interests include investigation into the treatment of acute coronary syndrome and cardiogenic shock. He has been involved in several multi-center trials, including TIMI 32, MCC-135 and TENACITY. He is currently the primary investigator for CHAMPION-PCI, a multi-center study using a novel inhibitor of platelet function for the treatment of acute coronary syndromes.

Publications:

Gogo P., Schneider D, Terrien E, Sobel B, Dauerman H. Osteoprotegerin is Not Associated with Angiographic Coronary Calcification. Journal of Thrombosis and Thrombolysis. In press.

Gogo P. The Evaluation and Management of Cardiogenic Shock. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 5(1):1-6, March 2006.

Gogo P, Schneider D, Watkins M, Terrien E, Sobel B, Dauerman H. Systemic Inflammation After Drug-Eluting Stent Placement. Journal of Thrombosis and Thrombolysis. 2005 Apr;19(2):87-92.

Gogo P, Schneider D, Terrien E, Watkins M, Sobel B. Dauerman H. Relation of Leukocytosis to C-Reactive Protein and Interluekin-6 Among Patients Undergoing Percutaneous Coronary Intervention. American Journal of Cardiology. 2005 Aug 15;96(4):538-42.

Cytokine Activation Before Percutaneous Coronary Intervention Reflects Clinical and Laboratory Variables Associated With Increased Risk. ACC 2005, Orlando, Florida. Poster abstract.